(Q44929056)

7 December 2017

title

Leflunomide-associated pancytopenia with or without methotrexate (English)

1 reference

7 December 2017

1 reference

Jonathan Chan

1

1 reference

7 December 2017

Daniela C Sanders

series ordinal

2

1 reference

7 December 2017

Leanne Du

series ordinal

3

1 reference

7 December 2017

Peter I Pillans

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

8 June 2004

1 reference

Annals of Pharmacotherapy

7 December 2017

published in

1 reference

7 December 2017

volume

38

1 reference

7 December 2017

issue

7-8

1 reference

7 December 2017

page(s)

1206-1211

1 reference

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

7 December 2017

cites work

1 reference

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Mechanism of action for leflunomide in rheumatoid arthritis

21 January 2018

1 reference

Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide

21 January 2018

1 reference

Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis

21 January 2018

1 reference

Pancytopenia associated with leflunomide and methotrexate

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

Leflunomide use during the first 33 months after food and drug administration approval: experience with a national cohort of 3,325 patients

21 January 2018

1 reference

Leflunomide: a review of its use in active rheumatoid arthritis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E012

1 reference

7 December 2017

1 reference